What should I Know Regarding Pregnancy, Nursing and Administering Albertsons Acid Reducer Tablet to Children or the Elderly?

If you are PREGNANT

• Requires a Risk/Benefit Assessment:
• FDA B (no known animal fetal risk. Unknown human fetal risk):
• FDA B (no known animal fetal risk. Unknown human fetal risk):

If you are NURSING

• Precaution: LOW AMOUNTS EXCRETED NOT LIKELY TO RESULT IN INFANT ADV EFFECTS
• Precaution: LIMITED DATA SUGGEST LOW AMOUNTS EXCRETED, WITH NO RESULTING EFFECT ON INFANT
• Precaution: INSUFFICIENT DATA AVAILABLE; LIMITED DATA SUGGEST AMOUNT EXCRETED IS MINIMAL

If you are an adult over 60

• Management or Monitoring Precaution: Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Dose adjustment may be required for CrCL<50 mL/min. to minimize CNS effects (e.g., mental status changes).
• Management or Monitoring Precaution: Neuro/Psych-Avoid in older adults with or at high risk of delirium or mental status changes. Renal-Reduce dose for CrCL < 50 mL/min
• Management or Monitoring Precaution: Neuro/Psych-Avoid in older adults with or at high risk of delirium because of inducing or worsening delirium. Avoid in elderly with dementia or cognitive impairment. Renal-Renal impairment may increase risk for confusion in elderly. Avoid or reduce dose for CrCl < 50 mL/min. Hepatic-Hepatic impairment may increase risk for confusion.

Giving Albertsons Acid Reducer Tablet to a child under 12

• Management or Monitoring Precaution: Limited pediatric data. Manufacturer does not recommend age < 16 years.